Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials.
about
Lymph node dissection (lymphadenectomy) for presumed early stage epithelial ovarian cancerAdjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerAdjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerInterventions for the treatment of borderline ovarian tumoursAdjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerFour cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer.Optimal treatment of early-stage ovarian cancer.Chemotherapy for ovarian cancer: current concepts.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.Current management of epithelial ovarian carcinoma: a review.International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.Proteomics and ovarian cancer: integrating proteomics information into clinical careRisk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probeA randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group StudyScreening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.New therapies for ovarian cancer.Prognostic role of CIP2A expression in serous ovarian cancerUse and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.Trends in relative survival for ovarian cancer from 1975 to 2011.Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer.First-line therapy for ovarian carcinoma: what's next?A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006Characteristics of Long-Term Survivors of Epithelial Ovarian CancerOvarian cancer biomarkers: current options and future promise.Cytoreductive surgery in ovarian cancer.The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?Recent progress in the diagnosis and treatment of ovarian cancerIn vitro chemosensitivity in ovarian carcinoma: Comparison of three leading assays.Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Progress in gynecologic cancer research: the Gynecologic Oncology Group experienceEarly detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.Comparison of Laparoscopy and Laparotomy in Surgical Staging of Apparent Early Ovarian Cancer: 13-year Experience.Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
P2860
Q24187026-A3818B4F-2ED5-48EC-8699-F357100C6EE9Q24187061-3017D994-4B24-4FC3-BB56-F38ED680CE8DQ24201216-456BA53A-F2CE-4301-B41D-BDE099B174AFQ24235347-704CFB63-9855-47A6-8D7E-C894E13692A1Q24240177-175A3B85-C9DE-4EF8-9ED8-7CE656560CB9Q30827244-CD776E28-EEED-442A-9423-E0A8C259A607Q33537387-BD6FA683-DA3F-400B-A918-66447BE67A29Q33618894-B4485298-BD64-45DF-B684-194AC791D0FBQ33683114-945A8511-93D7-4EC4-8A0B-6E65BC251BA7Q33742794-62566224-768A-47B9-AA38-EFE502FFC3A8Q33858073-2C241220-49C2-4B32-AA83-21BA8F7C8F60Q33915813-A2C94E26-13BC-403A-B92F-E06BC6399D36Q33959810-7F5A35EA-EA77-4F60-901C-0A8A1994E153Q33963742-BC9F30C2-F258-4782-8D8C-819A38F74A93Q34126627-24E30410-1B49-4FFD-AB99-9689A2ED5F58Q34327275-82CDE219-5E44-4882-B92A-FB3801864728Q34783824-5CBEEA93-04D2-4A0D-8715-DA85CF294819Q35033234-7E31E3FD-A327-4081-AAB8-BB9ED7FA0A07Q35187046-3A0F93A4-61A5-4FC0-BA46-8EDCB1F79AB3Q35259954-437A4D2A-5C8D-4A01-BAE2-FBF8DEB63252Q35263210-DEB1ABD1-DAEA-453D-A686-8628F46A4361Q35589020-DF6890FC-BA5F-47C6-AC3F-7D7299AE841EQ35647524-CAAFEDF2-36CB-4646-B60A-F1D9862AC553Q35792998-F56C4E74-75C6-4555-B1D2-C6CB8F0B3864Q35968742-25CAF9E6-BB25-4B54-BC7C-2538E61A5895Q35968748-575F9502-95EA-494F-9B91-514203D41701Q35980522-F396AA60-8212-4427-B733-8F1777A6EFBDQ35984294-39D91F68-C7E4-4E9B-B992-EBBD8C8E3A44Q36054395-43AA652D-C468-4500-AADC-EE1748B171A7Q36295219-D864764F-A7D6-46A1-BB8F-BD1C31BACF06Q36608535-31CD1318-93E8-4F54-B23E-CD1B8FD607DDQ36622857-14C8DA4C-DEB6-40F0-84C2-5E54C0BE8E96Q36692896-B0634FFB-F3C4-4924-88FE-674996616C64Q36932557-CD8DB821-ADF5-46AD-892B-4B6D3AA4BA5CQ36962482-F0C5D7DA-E384-48E4-B165-CB0727A543E2Q36979335-222A05A7-1804-4C00-84FC-7A629E442986Q36979840-AD1BF1E5-2FD7-475B-A036-687E658AAE3CQ36988242-9564E5B8-1BD7-4259-9E90-0FC1817CEF63Q36993096-38605B7B-4BAA-4D8D-857B-9C9EDCCB344BQ37094755-929ADE58-85D4-4671-8B92-763C8209E446
P2860
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Adjuvant therapy in stage I an ...... prospective randomized trials.
@ast
Adjuvant therapy in stage I an ...... prospective randomized trials.
@en
Adjuvant therapy in stage I an ...... prospective randomized trials.
@nl
type
label
Adjuvant therapy in stage I an ...... prospective randomized trials.
@ast
Adjuvant therapy in stage I an ...... prospective randomized trials.
@en
Adjuvant therapy in stage I an ...... prospective randomized trials.
@nl
prefLabel
Adjuvant therapy in stage I an ...... prospective randomized trials.
@ast
Adjuvant therapy in stage I an ...... prospective randomized trials.
@en
Adjuvant therapy in stage I an ...... prospective randomized trials.
@nl
P2093
P1476
Adjuvant therapy in stage I an ...... prospective randomized trials.
@en
P2093
Ellenberg SS
Homesley HD
Major F Jr
Wilbanks GD
P304
P356
10.1056/NEJM199004123221501
P407
P577
1990-04-01T00:00:00Z